Ensuring diagnostic testing accuracy for patient care and public health- COVID-19 testing scale-up from an EQA provider’s perspective

Author:

Restelli Veronica,Vimalanathan Selvarani,Sreya MahfuzaORCID,Noble Michael A.ORCID,Perrone Lucy A.ORCID

Abstract

In response to the coronavirus pandemic (COVID-19) and scale up of diagnostic testing, the Canadian Microbiology Proficiency Testing program created a new proficiency testing (PT) program for the molecular and antigen detection of SARS-CoV-2. The program was geared to point of care testing (POCT) sites located in each of the eight provincial Health Authorities across British Columbia, Canada, with the intention to monitor testing quality. The PT program consisted of 6 shipments in a year, each containing a set of 4 samples either positive for SARS-CoV-2 virus or negative. The program began with initial 23 sites enrolling in March 2021, expanding to >100 participants by December 2021. After the first two surveys, it was observed that testing performance (accuracy) was consistently acceptable for sites using nucleic acid technology (NAT), however performance by sites using rapid antigen detection (RAD) methods was poor, especially when testing the weakly positive samples. A root cause investigation of poor testing performance revealed gaps in the execution of testing methods and also in results interpretation. These quality issues were most commonly associated with new testers who lacked experience with diagnostic testing. Tester training and mentoring was reinforced as was retraining of personnel; sample processing instructions were modified, and a training video was also created for testing sites. As a result of these interventions, sites improved their testing accuracy and the performance of POCT sites using RAD methods came to more closely match the performance of sites utilizing NAT. Overall, the PT program was highly successfully and improved quality of testing in the province. This work demonstrates the critical value of an external quality assessment (EQA) partner towards improving patient and public health and safety, especially when testing is conducted outside of an accredited medical laboratory setting.

Funder

University of British Columbia

Publisher

Public Library of Science (PLoS)

Reference25 articles.

1. COVID-19—FIND [Internet]. [cited 2023 Nov 10]. Available from: https://www.finddx.org/covid-19/

2. Authorized medical devices for uses related to COVID-19: List of authorized testing devices—Canada.ca [Internet]. [cited 2023 Nov 10]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/authorized/list.html#a1.2

3. Canada PHA of. aem. 2022 [cited 2023 Nov 10]. Inequalities in the mental health of adults before and during the COVID-19 pandemic: summary. Available from: https://health-infobase.canada.ca/covid-19/mental-health-inequalities/summary.html

4. Canada PHA of. aem. 2020 [cited 2023 Nov 10]. COVID-19 daily epidemiology update: Summary. Available from: https://www.canada.ca/en.html

5. Services M of C. Population—Province of British Columbia [Internet]. Province of British Columbia; [cited 2023 Nov 10]. Available from: https://www2.gov.bc.ca/gov/content/data/statistics/people-population-community/population

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3